.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Diffuse Large B-Cell Lymphoma: Emerging Treatment Options

EP. 1: Treatment of Newly Diagnosed DLBCL

January 30th 2020

EP. 2: Prognostic Factors in DLBCL

January 30th 2020

EP. 3: Comorbidities and Role of R-CHOP in DLBCL

January 30th 2020

EP. 4: Optimization of PET Scans and Determining Relapse in DLBCL

January 30th 2020

EP. 5: Role of CNS Prophylaxis in DLBCL

January 30th 2020

EP. 6: Management of Relapsed/Refractory DLBCL

January 30th 2020

EP. 7: Treatment Alternatives to Chemotherapy in R/R DLBCL

January 30th 2020

EP. 8: Use of CAR T Therapy in R/R DLBCL

January 30th 2020

EP. 9: Safety and Efficacy of CAR T Therapy in R/R DLBCL

January 30th 2020

EP. 10: R/R DLBCL: CAR T Therapy and Immune Checkpoint Inhibition

January 30th 2020

EP. 11: Future Directions of CAR T Therapy in R/R DLBCL

January 30th 2020

EP. 12: L-MIND Trial in Relapsed/Refractory DLBCL

January 30th 2020

EP. 13: Emerging Agents in the Management of R/R DLBCL

January 30th 2020

EP. 14: Future Directions and Unmet Needs for Treatment of DLBCL

January 30th 2020